How does Rinvoq (upadacitinib) affect skin and trigger acne?
Rinvoq is a JAK inhibitor. By blocking Janus kinase (JAK) signaling, it changes immune and inflammatory pathways that normally help regulate skin cell behavior and inflammatory responses. When those signals shift, some people develop acne or acne-like eruptions.
Is the acne from Rinvoq true acne or a different rash?
People can describe drug-related lesions as “acne,” but JAK inhibitors can also cause broader inflammatory or follicular skin reactions. In practice, these eruptions may look like acne (comedones or inflamed bumps) but still reflect a medication-induced change in skin inflammation around hair follicles rather than a classic teenage acne pattern.
Why do JAK inhibitors sometimes worsen breakouts?
Acne is strongly linked to inflammation in and around hair follicles. JAK signaling also plays a role in how immune cells communicate and how inflammatory mediators are released. When that communication is altered by a JAK inhibitor, inflammatory signals in the skin can increase, making follicles more likely to become inflamed and produce acne-like lesions.
Who is more likely to get acne on Rinvoq?
Risk can be higher in people who already have acne-prone skin, a history of inflammatory acne, or other factors that predispose to folliculitis or skin inflammation. If you notice new or rapidly worsening bumps after starting or increasing Rinvoq, the timing often supports a medication-related reaction.
What should you do if acne starts after starting Rinvoq?
If you develop acne-like lesions after beginning Rinvoq, it’s reasonable to treat it as a medication-related skin reaction. Contact the prescriber if it is moderate to severe, widespread, painful, or not improving with usual over-the-counter acne care. The clinician may adjust other skincare or acne treatments and will decide whether Rinvoq should be continued.
When is acne a warning sign of something more serious?
Seek prompt medical advice if skin symptoms come with signs of a more serious drug reaction, such as fever, widespread rash, blistering, skin peeling, mouth sores, or eye involvement. These aren’t typical acne patterns and need urgent evaluation.
Could other brands of JAK inhibitors cause similar acne?
Yes. Because Rinvoq works via JAK inhibition, similar inflammatory and immune pathway effects can occur with other JAK inhibitors, making acne or acne-like eruptions possible across this drug class.
Is there a relationship between Rinvoq dose and acne?
Breakouts often track with when the drug is started or when the dose is increased, which suggests that higher immune pathway inhibition or changes in skin inflammation over time can contribute. If symptoms worsen after dose changes, tell your prescriber.
If you share your Rinvoq dose and when the acne started (and whether it’s on the face only or also chest/back), I can help you map the timing to likely medication-related patterns and what to ask your dermatologist or prescribing clinician.